Notice: Images are for illustration only and may not reflect the exact product you receive. Brand-name medications may look different depending on their country of origin—Canadian versions, for example, often include a "PR" symbol on the packaging. Rest assured, the medication, dosage, and active ingredients will be exactly as prescribed. Canada Pharmacy Store is committed to your health and safety, and we work only with licensed pharmacies to ensure you receive trusted, high-quality medication every time.
Ofev (Nintedanib)
| Nintedanib (Generic) Nintedanib | ||||||
|
Shipped from Mauritius | ||||||
| | ||||||
| Select product strength & quantity:
Who is the product for? YouOtherAdd Family Member/PetYou must be logged in to add additional members to the order. Don't have an account? or Add Family Member/PetSign inTo continue, please enter your email address and password that you use for your account. | ||||||
| Select product strength & quantity:
Who is the product for? YouOtherAdd Family Member/PetYou must be logged in to add additional members to the order. Don't have an account? or Add Family Member/PetSign inTo continue, please enter your email address and password that you use for your account. | ||||||
General Medication Fact Sheet for Ofev
| Field | Information |
|---|---|
| Medication Name | Ofev |
| Generic Name | Nintedanib |
| Boxed/Label Warning | Potential risk of serious liver problems, increased risk of bleeding, gastrointestinal perforations, and embryo-fetal toxicity. |
| Purpose | Treatment of idiopathic pulmonary fibrosis (IPF), systemic sclerosis-associated interstitial lung disease (SSc-ILD), and chronic fibrosing interstitial lung diseases with a progressive phenotype. |
| Mechanism of Action | Tyrosine kinase inhibitor that blocks multiple growth factor receptors involved in fibrosis. |
| Dosage Forms | Oral capsules |
| Available Strengths | 100 mg, 150 mg |
| Dosage Frequency | Twice daily |
| Common Side Effects | Diarrhea, nausea, abdominal pain, vomiting, decreased appetite, weight loss, headache, and elevated liver enzymes. |
| Serious Side Effects | Liver damage, bleeding problems, gastrointestinal perforation, arterial thromboembolic events, embryo-fetal toxicity, and increased risk of heart attack or stroke. |
| Drug Interactions | CYP3A4 inhibitors (e.g., ketoconazole) may increase nintedanib levels; CYP3A4 inducers (e.g., rifampin) may decrease nintedanib levels; anticoagulants may increase bleeding risk. |
| Important Notes | Administer with food. Monitor liver function regularly. Women of childbearing potential should use effective contraception. Consult a healthcare provider before taking any other medications or supplements. |
| Storage | Store at room temperature between 68°F to 77°F (20°C to 25°C). Protect from moisture. |
| Missed Dose | Take the missed dose as soon as you remember, unless it is less than 6 hours until your next scheduled dose. Do not take two doses at the same time. |
| Alternatives | Esbriet (pirfenidone), immunosuppressants (e.g., azathioprine, mycophenolate), corticosteroids (e.g., prednisone) |
Ofev Alternatives
| Medication | Mechanism of Action | Notes |
|---|---|---|
| Esbriet (pirfenidone) | Reduces fibrosis by affecting multiple pathways, including TGF-beta and TNF-alpha. | Used for IPF. May cause photosensitivity. |
| azathioprine | Immunosuppressant that inhibits purine synthesis. | Used in some ILDs, can increase risk of infection. |
| Mycophenolate Mofetil (CellCept) | Immunosuppressant that inhibits purine synthesis. | Used in some ILDs, requires regular blood monitoring. |
| Prednisone | Corticosteroid with anti-inflammatory and immunosuppressant properties. | Used in some ILDs, long-term use associated with numerous side effects. |
Ofev Side Effects
| Common Side Effects | Serious Side Effects |
|---|---|
| Diarrhea | Liver damage |
| Nausea | Bleeding problems |
| Abdominal pain | Gastrointestinal perforation |
| Vomiting | Arterial thromboembolic events (heart attack, stroke) |
| Decreased appetite | Embryo-fetal toxicity |
| Weight loss | Increased risk of heart attack or stroke |
Ofev Dosage Guide
| Condition | Starting Dose | Maintenance Dose | Administration Notes |
|---|---|---|---|
| Idiopathic Pulmonary Fibrosis (IPF) | 150 mg twice daily | 150 mg twice daily | Administer with food. Reduce dose to 100 mg twice daily if side effects occur. |
| Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD) | 150 mg twice daily | 150 mg twice daily | Administer with food. Reduce dose to 100 mg twice daily if side effects occur. |
| Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype | 150 mg twice daily | 150 mg twice daily | Administer with food. Reduce dose to 100 mg twice daily if side effects occur. |
Ofev Price With And Without Insurance
| Purchase Context | Estimated Price |
|---|---|
| With Insurance | $250 |
| Without Insurance (U.S.) | $9000 – $9,500 |
| From CPS | $2,685.35 |
